DexCom, Inc. (DXCM)

67.27 +0.41 (+0.61%) USD  |  NASDAQ  |  Dec 24, 10:46
More

DexCom SG&A Expense (TTM): 1.297B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 12.11B
BioLife Solutions, Inc. 56.57M
Boston Scientific Corp. 6.666B
Tandem Diabetes Care, Inc. 437.73M
Sotera Health Co. 257.08M